{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:34:40Z","timestamp":1773934480734,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Palacky University Olomouc","award":["IGA LF 2023_037"],"award-info":[{"award-number":["IGA LF 2023_037"]}]},{"name":"Palacky University Olomouc","award":["IGA LF 2024_040"],"award-info":[{"award-number":["IGA LF 2024_040"]}]},{"name":"Palacky University Olomouc","award":["IGA LF 2024_040"],"award-info":[{"award-number":["IGA LF 2024_040"]}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["MH CZ DRO (FNOl, 00098892)"],"award-info":[{"award-number":["MH CZ DRO (FNOl, 00098892)"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["MH CZ DRO (FNOl, 00098892)"],"award-info":[{"award-number":["MH CZ DRO (FNOl, 00098892)"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["MH CZ DRO (FNOl, 00098892)"],"award-info":[{"award-number":["MH CZ DRO (FNOl, 00098892)"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adipose tissue is significantly involved in inflammatory bowel disease (IBD). Vitamin D can affect both adipogenesis and inflammation. The aim of this study was to compare the production of selected adipokines, potentially involved in the pathogenesis of IBD - adiponectin, resistin, retinol binding protein 4 (RBP-4), adipocyte fatty acid binding protein and nesfatin-1 in children with IBD according to the presence of 25-hydroxyvitamin D (25(OH)D) deficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study was conducted as a case-control study in pediatric patients with IBD and healthy children of the same sex and age. In addition to adipokines and 25(OH)D, anthropometric parameters, markers of inflammation and disease activity were assessed in all participants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Children with IBD had significantly higher resistin levels regardless of 25(OH)D levels. IBD patients with 25(OH)D deficiency only had significantly lower RBP-4 compared to healthy controls and also compared to IBD patients without 25(OH)D deficiency. No other significant differences in adipokines were found in children with IBD with or without 25(OH)D deficiency. 25(OH)D levels in IBD patients corelated with RBP-4 only, and did not correlate with other adipokines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Whether the lower RBP-4 levels in the 25(OH)D-deficient group of IBD patients directly reflect vitamin D deficiency remains uncertain. The production of other adipokines does not appear to be directly related to vitamin D deficiency.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-024-04890-0","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T13:03:47Z","timestamp":1720011827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of selected adipokines with vitamin D deficiency in children with inflammatory bowel disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Milos","family":"Geryk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Kucerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Velganova-Veghova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Foltenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Bouchalova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Karasek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Radvansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Karaskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"issue":"4","key":"4890_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1586\/eci.10.46","volume":"6","author":"A Bousvaros","year":"2010","unstructured":"Bousvaros A. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease. Expert Rev Clin Immunol. 2010;6(4):659\u201366.","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"4890_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2013.240","volume":"11","author":"J Ruel","year":"2014","unstructured":"Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum\u2014is it the same disease? Nat Rev Gastroenterol Hepatol. 2014;11(2):88\u201398.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4890_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MIB.0000000000000209","volume":"21","author":"P Gon\u00e7alves","year":"2015","unstructured":"Gon\u00e7alves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis. 2015;21(2):453\u201367.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"4890_CR4","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.3390\/ijms22084226","volume":"22","author":"E Karaskova","year":"2021","unstructured":"Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of adipose tissue in inflammatory bowel disease. Int J Mol Sci. 2021;22(8):4226.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4890_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MOG.0000000000000449","volume":"34","author":"J Gubatan","year":"2018","unstructured":"Gubatan J, Moss AC. Vitamin D in inflammatory bowel disease: more than just a supplement. Curr Opin Gastroenterol. 2018;34(4):217\u201325.","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"4890_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5217\/ir.2019.00078","volume":"17","author":"JY Yoon","year":"2019","unstructured":"Yoon JY. Nutritional approach as therapeutic manipulation in inflammatory bowel disease. Intest Res. 2019;17(4):463\u201375.","journal-title":"Intest Res"},{"issue":"1","key":"4890_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5409\/wjcp.v8.i1.1","volume":"8","author":"T Rigterink","year":"2019","unstructured":"Rigterink T, Appleton L, Day AS. Vitamin D therapy in children with inflammatory bowel disease: a systematic review. World J Clin Pediatr. 2019;8(1):1\u201314.","journal-title":"World J Clin Pediatr"},{"issue":"3","key":"4890_CR8","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3748\/wjg.v22.i3.933","volume":"22","author":"S Meeker","year":"2016","unstructured":"Meeker S, Seamons A, Maggio-Price L, Paik J. Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol. 2016;22(3):933\u201348.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4890_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.17113\/ftb.56.04.18.5805","volume":"56","author":"D Leskovar","year":"2018","unstructured":"Leskovar D, Me\u0161trovi\u0107 T, Bare\u0161i\u0107 A, Kraljevi\u0107 I, Panek M, \u010cip\u010di\u0107 Paljetak H, et al. The role of vitamin D in inflammatory bowel disease - assessing therapeutic and preventive potential of supplementation and food fortification. Food Technol Biotechnol. 2018;56(4):455\u201363.","journal-title":"Food Technol Biotechnol"},{"issue":"11","key":"4890_CR10","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1097\/MIB.0000000000000546","volume":"21","author":"R Del Pinto","year":"2015","unstructured":"Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F. Association between inflammatory bowel disease and vitamin D deficiency: a systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21(11):2708\u201317.","journal-title":"Inflamm Bowel Dis"},{"key":"4890_CR11","doi-asserted-by":"publisher","first-page":"1007725","DOI":"10.3389\/fnut.2022.1007725","volume":"9","author":"S Fatahi","year":"2023","unstructured":"Fatahi S, Alyahyawi N, Albadawi N, Mardali F, Dara N, Sohouli MH, et al. The association between vitamin D status and inflammatory bowel disease among children and adolescents: a systematic review and meta-analysis. Front Nutr. 2023;9:1007725.","journal-title":"Front Nutr"},{"key":"4890_CR12","doi-asserted-by":"publisher","first-page":"1155004","DOI":"10.3389\/fped.2023.1155004","volume":"11","author":"YH Sun","year":"2023","unstructured":"Sun YH, Tian DD, Zhou JM, Ye Q. Association between vitamin D level and pediatric inflammatory bowel disease: a systematic review and meta-analysis. Front Pediatr. 2023;11:1155004.","journal-title":"Front Pediatr"},{"issue":"7","key":"4890_CR13","doi-asserted-by":"publisher","first-page":"e101583","DOI":"10.1371\/journal.pone.0101583","volume":"9","author":"LE Veit","year":"2014","unstructured":"Veit LE, Maranda L, Fong J, Nwosu BU. The vitamin D status in inflammatory bowel disease. PLoS ONE. 2014;9(7):e101583.","journal-title":"PLoS ONE"},{"issue":"2","key":"4890_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/ijms23020956","volume":"23","author":"I Szymczak-Pajor","year":"2022","unstructured":"Szymczak-Pajor I, Miazek K, Selmi A, Balcerczyk A, \u015aliwi\u0144ska A. The Action of Vitamin D in adipose tissue: is there the link between vitamin D Deficiency and Adipose tissue-related metabolic disorders? Int J Mol Sci. 2022;23(2):956.","journal-title":"Int J Mol Sci"},{"key":"4890_CR15","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3389\/fimmu.2018.01974","volume":"9","author":"C Weidinger","year":"2018","unstructured":"Weidinger C, Ziegler JF, Letizia M, Schmidt F, Siegmund B. Adipokines and their role in intestinal inflammation. Front Immunol. 2018;9:1974.","journal-title":"Front Immunol"},{"issue":"2","key":"4890_CR16","first-page":"275","volume":"71","author":"E Karaskova","year":"2022","unstructured":"Karaskova E, Kubickova V, Velganova-Veghova M, Geryk M, Foltenova H, Karasek D. Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease. Physiol Res. 2022;71(2):275\u201384.","journal-title":"Physiol Res"},{"issue":"2","key":"4890_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nut.2008.07.020","volume":"25","author":"L Valentini","year":"2009","unstructured":"Valentini L, Wirth EK, Schweizer U, Hengstermann S, Schaper L, Koernicke T, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition. 2009;25(2):172\u201381.","journal-title":"Nutrition"},{"issue":"4","key":"4890_CR18","first-page":"360","volume":"16","author":"E Roma","year":"2012","unstructured":"Roma E, Krini M, Hantzi E, Sakka S, Panayiotou I, Margeli A, Papassotiriou I, Kanaka-Gantenbein C. Retinol binding protein 4 in children with inflammatory bowel disease: a negative correlation with the disease activity. Hippokratia. 2012;16(4):360\u20135.","journal-title":"Hippokratia"},{"issue":"9","key":"4890_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MEG.0b013e3282202bca","volume":"19","author":"K Karmiris","year":"2007","unstructured":"Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Kouroumalis EA. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2007;19(9):789\u201394.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1160","key":"4890_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/postgradmedj-2020-139227","volume":"98","author":"\u015e Beyaz","year":"2022","unstructured":"Beyaz \u015e, Akbal E. Increased serum nesfatin-1 levels in patients with inflammatory bowel diseases. Postgrad Med J. 2022;98(1160):446\u20139.","journal-title":"Postgrad Med J"},{"issue":"12","key":"4890_CR21","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1007\/s10620-017-4806-5","volume":"62","author":"N Morshedzadeh","year":"2017","unstructured":"Morshedzadeh N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, Reza Zali M, Mirmiran P. Association between adipokines levels with inflammatory bowel disease (IBD): systematic reviews. Dig Dis Sci. 2017;62(12):3280\u20136.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"4890_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","volume":"58","author":"A Levine","year":"2014","unstructured":"Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795\u2013806.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"4890_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/01.mpg.0000183350.46795.42","volume":"41","author":"J Hyams","year":"2005","unstructured":"Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Pediatric Inflammatory Bowel Disease Collaborative Research Group, et al. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr. 2005;41(4):416\u201321.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4890_CR24","doi-asserted-by":"crossref","unstructured":"Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol. 2018;84(10):2194\u20132207.","DOI":"10.1111\/bcp.13652"},{"issue":"8","key":"4890_CR25","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/ibd.20867","volume":"15","author":"D Turner","year":"2009","unstructured":"Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, et al. Pediatric IBD Collaborative Research Group. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009;15(8):1218\u201323.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"4890_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266\u201381.","journal-title":"N Engl J Med"},{"issue":"2","key":"4890_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1542\/peds.2007-1894","volume":"122","author":"M Misra","year":"2008","unstructured":"Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122(2):398\u2013417.","journal-title":"Pediatrics"},{"issue":"2","key":"4890_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/01.MIB.0000200345.38837.46","volume":"12","author":"K Karmiris","year":"2006","unstructured":"Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(2):100\u20135.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"4890_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/MEG.0b013e3282f16251","volume":"19","author":"A Konrad","year":"2007","unstructured":"Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenk\u00fchn T, et al. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007;19(12):1070\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"4890_CR30","doi-asserted-by":"publisher","first-page":"100487","DOI":"10.1016\/j.mcpro.2022.100487","volume":"22","author":"ASC Louis Sam Titus","year":"2023","unstructured":"Louis Sam Titus ASC, Vanarsa K, Soomro S, Patel A, Prince J, Kugathasan S, et al. Resistin, Elastase, and Lactoferrin as potential plasma biomarkers of Pediatric Inflammatory Bowel Disease based on Comprehensive Proteomic screens. Mol Cell Proteom. 2023;22(2):100487.","journal-title":"Mol Cell Proteom"},{"issue":"12","key":"4890_CR31","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.bbamcr.2009.09.008","volume":"1793","author":"EA Bostr\u00f6m","year":"2009","unstructured":"Bostr\u00f6m EA, Tarkowski A, Bokarewa M. Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli. Biochim Biophys Acta. 2009;1793(12):1894\u2013900.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"4890_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/0003319714543512","volume":"66","author":"E Stoki\u0107","year":"2015","unstructured":"Stoki\u0107 E, Kupusinac A, Tomic-Naglic D, Smiljenic D, Kovacev-Zavisic B, Srdic-Galic B, et al. Vitamin D and dysfunctional adipose tissue in obesity. Angiology. 2015;66(7):613\u20138.","journal-title":"Angiology"},{"key":"4890_CR33","doi-asserted-by":"publisher","first-page":"615440","DOI":"10.3389\/fendo.2020.615440","volume":"11","author":"S Tariq","year":"2021","unstructured":"Tariq S, Tariq S, Khaliq S, Baig M, Murad MA, Lone KP. Association between Vitamin D and resistin in postmenopausal females with altered Bone Health. Front Endocrinol (Lausanne). 2021;11:615440.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4890_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12020-010-9379-4","volume":"38","author":"N Vilarrasa","year":"2010","unstructured":"Vilarrasa N, Vendrell J, Maravall J, El\u00edo I, Solano E, San Jos\u00e9 P, et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010;38(2):235\u201342.","journal-title":"Endocrine"},{"key":"4890_CR35","doi-asserted-by":"publisher","first-page":"495101","DOI":"10.1155\/2011\/495101","volume":"2011","author":"CL Roth","year":"2011","unstructured":"Roth CL, Elfers C, Kratz M, Hoofnagle AN. Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines. J Obes. 2011;2011:495101.","journal-title":"J Obes"},{"key":"4890_CR36","doi-asserted-by":"publisher","first-page":"659977","DOI":"10.3389\/fphys.2021.659977","volume":"12","author":"JS Steinhoff","year":"2021","unstructured":"Steinhoff JS, Lass A, Schupp M. Biological functions of RBP4 and its relevance for Human diseases. Front Physiol. 2021;12:659977.","journal-title":"Front Physiol"},{"issue":"3","key":"4890_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF03401305","volume":"12","author":"D Metheniti","year":"2013","unstructured":"Metheniti D, Sakka S, Dracopoulou M, Margeli A, Papassotiriou I, Kanaka-Gantenbein C, et al. Decreased circulating 25-(OH) vitamin D concentrations in obese female children and adolescents: positive associations with Retinol binding Protein-4 and Neutrophil Gelatinase-associated Lipocalin. Horm (Athens). 2013;12(3):397\u2013404.","journal-title":"Horm (Athens)"},{"issue":"3","key":"4890_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2249.2012.04660.x","volume":"170","author":"VS Rodrigues","year":"2012","unstructured":"Rodrigues VS, Milanski M, Fagundes JJ, Torsoni AS, Ayrizono ML, Nunez CE, et al. Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn\u2019s disease. Clin Exp Immunol. 2012;170(3):358\u201364.","journal-title":"Clin Exp Immunol"},{"key":"4890_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2147\/TCRM.S140618","volume":"13","author":"R Kahraman","year":"2017","unstructured":"Kahraman R, Calhan T, Sahin A, Ozdil K, Caliskan Z, Bireller ES, et al. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease? Ther Clin Risk Manag. 2017;13:1295\u2013301.","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"4890_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ibd.21091","volume":"16","author":"J Weigert","year":"2010","unstructured":"Weigert J, Obermeier F, Neumeier M, Wanninger J, Filarsky M, Bauer S, et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn\u2019s disease. Inflamm Bowel Dis. 2010;16(4):630\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"22","key":"4890_CR41","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.3748\/wjg.v20.i22.6912","volume":"20","author":"M Waluga","year":"2014","unstructured":"Waluga M, Hartleb M, Boryczka G, Kukla M, Zwirska-Korczala K. Serum adipokines in inflammatory bowel disease. World J Gastroenterol. 2014;20(22):6912\u20137.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4890_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/pr.2013.114","volume":"74","author":"G Chouliaras","year":"2013","unstructured":"Chouliaras G, Panayotou I, Margoni D, Mantzou E, Pervanidou P, Manios Y, et al. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn\u2019s disease and ulcerative colitis. Pediatr Res. 2013;74(4):420\u20136.","journal-title":"Pediatr Res"},{"issue":"1","key":"4890_CR43","doi-asserted-by":"publisher","first-page":"18027","DOI":"10.1038\/s41598-020-74999-6","volume":"10","author":"L Ortega Moreno","year":"2020","unstructured":"Ortega Moreno L, Sanz-Garcia A, de la Fern\u00e1ndez MJ, Arroyo Solera R, Fern\u00e1ndez-Tom\u00e9 S, Marin AC, et al. Serum adipokines as non-invasive biomarkers in Crohn\u2019s disease. Sci Rep. 2020;10(1):18027.","journal-title":"Sci Rep"},{"issue":"1","key":"4890_CR44","doi-asserted-by":"publisher","first-page":"e83685","DOI":"10.1371\/journal.pone.0083685","volume":"9","author":"GE Walker","year":"2014","unstructured":"Walker GE, Ricotti R, Roccio M, Moia S, Bellone S, Prodam F, et al. Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PLoS ONE. 2014;9(1):e83685.","journal-title":"PLoS ONE"},{"key":"4890_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fpubh.2014.00193","volume":"2","author":"A Bidulescu","year":"2014","unstructured":"Bidulescu A, Morris AA, Stoyanova N, Meng YX, Vaccarino V, Quyyumi AA, et al. Association between Vitamin D and Adiponectin and its relationship with body Mass Index: the META-Health study. Front Public Health. 2014;2:193.","journal-title":"Front Public Health"},{"issue":"1","key":"4890_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/oby.2011.210","volume":"20","author":"A Vaidya","year":"2012","unstructured":"Vaidya A, Williams JS, Forman JP. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obes (Silver Spring). 2012;20(1):186\u201391.","journal-title":"Obes (Silver Spring)"},{"issue":"2","key":"4890_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ejcn.2013.233","volume":"68","author":"LL Husemoen","year":"2014","unstructured":"Husemoen LL, Skaaby T, Martinussen T, J\u00f8rgensen T, Thuesen BH, Kistorp C, et al. Investigating the causal effect of vitamin D on serum adiponectin using a mendelian randomization approach. Eur J Clin Nutr. 2014;68(2):189\u201395.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"4890_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2337\/dc11-1944","volume":"35","author":"S Parikh","year":"2012","unstructured":"Parikh S, Guo DH, Pollock NK, Petty K, Bhagatwala J, Gutin B, et al. Circulating 25-hydroxyvitamin D concentrations are correlated with cardiometabolic risk among American black and white adolescents living in a year-round sunny climate. Diabetes Care. 2012;35(5):1133\u20138.","journal-title":"Diabetes Care"},{"key":"4890_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yclnex.2018.10.004","volume":"23","author":"M Carvalho-Rassbach","year":"2019","unstructured":"Carvalho-Rassbach M, Alvarez-Leite JI, de F\u00e1tima. Haueisen Sander Diniz M. is the association between vitamin D, adiponectin, and insulin resistance present in normal weight or obese? A pilot study. Clin Nutr Exp. 2019;23:80\u20138.","journal-title":"Clin Nutr Exp"},{"issue":"6","key":"4890_CR50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1139\/cjpp-2012-0436","volume":"91","author":"OR Wright","year":"2013","unstructured":"Wright OR, Hickman IJ, Petchey WG, Sullivan CM, Ong C, Rose FJ, et al. The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin? Can J Physiol Pharmacol. 2013;91(6):496\u2013501.","journal-title":"Can J Physiol Pharmacol"},{"issue":"6","key":"4890_CR51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4274\/jcrpe.v1i6.262","volume":"1","author":"B \u00d6zkan","year":"2009","unstructured":"\u00d6zkan B, D\u00f6neray H, Keskin H. The effect of vitamin D treatment on serum adiponectin levels in children with vitamin D deficiency rickets. J Clin Res Pediatr Endocrinol. 2009;1(6):262\u20135.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"4890_CR52","doi-asserted-by":"publisher","first-page":"105925","DOI":"10.1016\/j.jsbmb.2021.105925","volume":"212","author":"B Nikooyeh","year":"2021","unstructured":"Nikooyeh B, Neyestani TR. Can vitamin D be considered an adiponectin secretagogue? A systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2021;212:105925.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04890-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T13:07:00Z","timestamp":1720012020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04890-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4890"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04890-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,3]]},"assertion":[{"value":"20 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the principles of the Declaration of Helsinki for experiments involving humans. This study protocol was reviewed and approved by the Ethics Committee of the Faculty of Medicine and University Hospital Olomouc (Approval number 136\/90). All participants and their parents received full study information and signed an informed consent prior to enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}